Inventor · disambiguated record
Serge Boyer
Also filed as: BOYER SERGE · BOYER SERGE H · BOYER SERGE HENRI
45 granted patents·11 pending applications·585 citations·filing 1995–2024
98Inventor score
Files withMETABASIS THERAPEUTICS INC20REMPEX PHARMACEUTICALS INC13MELINTA SUBSIDIARY CORP9ERION MARK D3VIKING THERAPEUTICS INC3
Top patents by PatentIndex Score
56 records- 0197US9694025B2Cyclic boronic acid ester derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2016·Granted Jul 4, 2017·21 cites·14 claims
- 0296US10004758B2Cyclic boronic acid ester derivatives and methods of making the sameREMPEX PHARMACEUTICALS INC·Filed 2017·Granted Jun 26, 2018·18 cites·30 claims
- 0396US9296763B2Cyclic boronic acid ester derivatives and therapeutic uses thereofREMPEX PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·27 cites·24 claims
- 0496US8680136B2Cyclic boronic acid ester derivatives and therapeutic uses thereofHIRST GAVIN·Filed 2011·Granted Mar 25, 2014·69 cites·27 claims
- 0595US11090319B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesMELINTA SUBSIDIARY CORP·Filed 2020·Granted Aug 17, 2021·3 cites·9 claims
- 0695US9012491B2Heterocyclic boronic acid ester derivatives and therapeutic uses thereofREDDY RAJA K·Filed 2012·Granted Apr 21, 2015·27 cites·39 claims
- 0794US7514419B2Phosphorus-containing thyromimeticsMETABASIS THERAPEUTICS INC·Filed 2005·Granted Apr 7, 2009·25 cites·18 claims
- 0893US10639318B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesREMPEX PHARMACEUTICALS INC·Filed 2018·Granted May 5, 2020·3 cites·21 claims
- 0993US10183034B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesREMPEX PHARMACEUTICALS INC·Filed 2018·Granted Jan 22, 2019·7 cites·29 claims
- 1093US10172874B2Pharmaceutical compositions comprising cyclic boronic acid ester derivativesREMPEX PHARMACEUTICALS INC·Filed 2018·Granted Jan 8, 2019·7 cites·24 claims
- 1192US5674998AC-4' modified adenosine kinase inhibitorsGENSIA INC·Filed 1995·Granted Oct 7, 1997·109 cites·44 claims
- 1292US2025064838A1Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesMELINTA SUBSIDIARY CORP·Filed 2024·Application pending·0 cites
- 1390US12161656B2Tetracycline compositionsMELINTA SUBSIDIARY CORP·Filed 2024·Granted Dec 10, 2024·0 cites·30 claims
- 1490US7553826B2Cytarabine monophosphate prodrugsMETABASIS THERAPEUTICS INC·Filed 2006·Granted Jun 30, 2009·11 cites·29 claims
- 1590US2025049820A1Tetracycline compositionsMELINTA SUBSIDIARY CORP·Filed 2024·Application pending·0 cites
- 1689US11951114B2Use of thyroid beta-agonistsVIKING THERAPEUTICS INC·Filed 2022·Granted Apr 9, 2024·1 cites·6 claims
- 1789US5763596AC-4' modified adenosine kinase inhibitorsMETABASIS THERAPEUTICS INC·Filed 1996·Granted Jun 9, 1998·117 cites·32 claims
- 1888US12171772B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesMELINTA SUBSIDIARY CORP·Filed 2023·Granted Dec 24, 2024·0 cites·5 claims
- 1988US7816345B2Phosphorus-containing prodrugsMETABASIS THERAPEUTICS INC·Filed 2007·Granted Oct 19, 2010·8 cites·55 claims
- 2087US9278105B2Tetracycline compositionsREMPEX PHARMACEUTICALS INC·Filed 2012·Granted Mar 8, 2016·6 cites·60 claims
- 2187US8710236B2Antagonists of the glucagon receptorGOMEZ-GALENO JORGE E·Filed 2011·Granted Apr 29, 2014·10 cites·5 claims
- 2287US7829552B2Phosphorus-containing thyromimeticsMETABASIS THERAPEUTICS INC·Filed 2004·Granted Nov 9, 2010·24 cites·16 claims
- 2386US11351183B2Use of thyroid beta-agonistsVIKING THERAPEUTICS INC·Filed 2017·Granted Jun 7, 2022·6 cites·20 claims
- 2486US9701626B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2015·Granted Jul 11, 2017·5 cites·10 claims
- 2586US9169201B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2014·Granted Oct 27, 2015·8 cites·13 claims
- 2686US8962618B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofREDDY K RAJA·Filed 2012·Granted Feb 24, 2015·7 cites·6 claims
- 2785US10034891B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·2 cites·4 claims
- 2885US7205404B1Phosphorus-containing prodrugsMETABASIS THERAPEUTICS INC·Filed 2000·Granted Apr 17, 2007·17 cites·61 claims
- 2985US7151092B2Cytarabine monophosphate prodrugsMETABASIS THERAPEUTICS INC·Filed 2003·Granted Dec 19, 2006·13 cites·11 claims
- 3084US8080536B2Phosphorus-containing prodrugsERION MARK D·Filed 2010·Granted Dec 20, 2011·6 cites·26 claims
- 3183US8664195B2Phosphorus-containing prodrugsERION MARK D·Filed 2011·Granted Mar 4, 2014·5 cites·78 claims
- 3283US7498320B2Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugsMETABASIS THERAPEUTICS INC·Filed 2006·Granted Mar 3, 2009·5 cites·64 claims
- 3382US11286270B2Boronic acid derivatives and synthesis thereofQPEX BIOPHARMA INC·Filed 2018·Granted Mar 29, 2022·3 cites·69 claims
- 3482US9340566B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2015·Granted May 17, 2016·2 cites·10 claims
- 3582US9084802B2Tetracycline compositionsREMPEX PHARMACEUTICALS INC·Filed 2014·Granted Jul 21, 2015·3 cites·31 claims
- 3680US11684629B2Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivativesMELINTA SUBSIDIARY CORP·Filed 2021·Granted Jun 27, 2023·0 cites·5 claims
- 3780US10239829B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2017·Granted Mar 26, 2019·2 cites·20 claims
- 3878US12440502B2Use of thyroid beta-agonistsVIKING THERAPEUTICS INC·Filed 2024·Granted Oct 14, 2025·0 cites·7 claims
- 3978US2024279248A1Synthesis of boronate ester derivatives and uses thereofMELINTA SUBSIDIARY CORP·Filed 2024·Application pending·0 cites
- 4077US11944634B2Tetracycline compositionsMELINTA SUBSIDIARY CORP·Filed 2019·Granted Apr 2, 2024·0 cites·25 claims
- 4176US10709718B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2018·Granted Jul 14, 2020·1 cites·11 claims
- 4276US7148349B2Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugsMETABASIS THERAPEUTICS INC·Filed 2003·Granted Dec 12, 2006·7 cites·80 claims
- 4368US10807946B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2019·Granted Oct 20, 2020·0 cites·10 claims
- 4468US9744179B2Tetracycline compositionsREMPEX PHARMACEUTICALS INC·Filed 2014·Granted Aug 29, 2017·0 cites·32 claims
- 4567US10669292B2Synthesis of boronate salts and uses thereofREMPEX PHARMACEUTICALS INC·Filed 2019·Granted Jun 2, 2020·0 cites·20 claims
- 4665US11999757B2Synthesis of boronate ester derivatives and uses thereofMELINTA SUBSIDIARY CORP·Filed 2018·Granted Jun 4, 2024·0 cites·16 claims
- 4764US2018078570A1Tetracycline compositionsREMPEX PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4861US2007249564A1Novel phosphorus-containing prodrugsMETABASIS THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4961US2019127396A1Synthesis of boronate ester derivatives and uses thereofREMPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 5059US10385074B2Synthesis of boronate salts and uses thereofREMPEX PHARMACEUTICALS INC·Filed 2015·Granted Aug 20, 2019·0 cites·26 claims
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →